Global Epigenetics Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Epigenetics Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Based on product, the global market for epigenetics, is segmented into enzymes, instruments and consumables, kits, reagents, and bioinformatics tools. In 2017, the kits segment accounted for the largest share of global market for epigenetics. The large share of this segment is attributed to the fact that a large number of kits are used in epigenetic techniques. The rising prevalence of a number of diseases, increasing R&D spending, and increased government funding for life science research are the Others factors supporting market growth.
Epigenetics report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Epigenetics market is projected to reach US$ 27650 million in 2029, increasing from US$ 9007.4 million in 2022, with the CAGR of 17.1% during the period of 2024 to 2029. Demand from Academic & Research Institutes and Pharmaceutical Companies are the major drivers for the industry.
Market growth can be attributed to the decreasing sequencing costs, increase in research activities, availability of funding for epigenetics research, and rising prevalence of cancer.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Epigenetics market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
Thermo Fisher Scientific
Merck & Co.
Zymo Research
Abcam
Qiagen
Illumina
Active Motif
Bio-Rad
New England Biolabs
Agilent
Perkinelmer
Diagenode
Epizyme Inc.
CellCentric Ltd.
ValiRx plc
EpiGentek
Segment by Type
Enzymes
Kits & Assays
Instruments and Consumables
Reagents
Academic & Research Institutes
Pharmaceutical Companies
Biotechnology Companies
Contract Research Organizations (CROs)
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Epigenetics market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2024, 2024-2029).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Epigenetics introduction, etc. Epigenetics Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12Mr Accuracy reports’s Conclusions of Epigenetics market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports.
Epigenetics report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Epigenetics market is projected to reach US$ 27650 million in 2029, increasing from US$ 9007.4 million in 2022, with the CAGR of 17.1% during the period of 2024 to 2029. Demand from Academic & Research Institutes and Pharmaceutical Companies are the major drivers for the industry.
Market growth can be attributed to the decreasing sequencing costs, increase in research activities, availability of funding for epigenetics research, and rising prevalence of cancer.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Epigenetics market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
By Company
Thermo Fisher Scientific
Merck & Co.
Zymo Research
Abcam
Qiagen
Illumina
Active Motif
Bio-Rad
New England Biolabs
Agilent
Perkinelmer
Diagenode
Epizyme Inc.
CellCentric Ltd.
ValiRx plc
EpiGentek
Segment by Type
Enzymes
Kits & Assays
Instruments and Consumables
Reagents
Segment by Application
Academic & Research Institutes
Pharmaceutical Companies
Biotechnology Companies
Contract Research Organizations (CROs)
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Epigenetics market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2024, 2024-2029).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Epigenetics introduction, etc. Epigenetics Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12Mr Accuracy reports’s Conclusions of Epigenetics market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports.